Open AccessPharmacovigilance in radiopharmaceuticals
Author(s) -
Rakesh Kumar,
Vivekanandan Kalaiselvan,
Rakesh Kumar,
Ravendra Verma,
Gyanendra Singh
Publication year - 2016
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.178252
Subject(s) - medicine , pharmacovigilance , pharmacopoeia , traditional medicine , alternative medicine , adverse drug reaction , medical physics , adverse effect , intensive care medicine , pharmacology , drug , pathology
Indian Pharmacopoeia Commission is Committed for maintaining the standards of drugs including Radiopharmaceuticals (RPs) by publishing Indian Pharmacopoeia. These RPs are being used in India for diagnostic or therapeutic purpose. RPs though contain relatively small quantities of active ingredient and administered in small volumes could cause some adverse reactions to the patients. The objective of presenting this article is to introduce the system of adverse drug reaction reporting to the nuclear medicine fraternity who are dealing with RPs.